Therefore, it is speculated that decreased IGFBP3 levels may lead to decreased bone volume fraction and bone density in AIS patients, and abnormal GH/IGF axis may be a potential pathogenesis of AIS. The gene discussed is IGF1; the disease is androgen insensitivity syndrome.